MedTrace Logo

Pain Management After Elective Shoulder Surgery

NCT03541759 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2018-06-01

No results posted yet for this study

Summary

Postoperative pain management plays an important role in elective shoulder surgery. The aim of this randomized quantitative study is to compare two frequently used postoperative pain regimes (hydromorphone versus piritramide) regarding onset and duration after the effectiveness of the single-shot interscalene block has diminished.

Conditions

  • Postoperative Pain

Interventions

DRUG

Hydromorphone Hcl 4Mg Tab

Hydal retard 4Mg Tab 2 times after surgery as basic medication. Hydal retard 2.6Mg maximum 2 per 24h when NRS \> 5.

DRUG

Piritramide 15mg s.c.

Dipidolor 15mg s.c. 2 times after surgery as basic medication. Dipidolor 7.5mg s.c. maximum 2 per 24h when NRS \> 5.

Sponsors & Collaborators

  • AUVA Traumazentrum Vienna Site UKH Meidling

    lead OTHER

Principal Investigators

  • Heinz Steltzer, MD, Prof. · Trauma Center Vienna Meidling

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2018-05-15
Completion
2018-05-17

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03541759 on ClinicalTrials.gov